# 3D Systems Corp: Form 10-Q for the period ended Mar 31, 2020

- Company: [3D Systems Corp](/companies/ddd.md) (CIK 910638)
- Form: 10-Q
- Filed: 2020-05-06
- Accepted by EDGAR: May 6, 2020, 16:07 ET
- Period: 2020-03-31
- Accession: 0000910638-20-000018
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/910638/000091063820000018/ddd-20200331.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/910638/000091063820000018/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2020-03-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2020-01-01 to 2020-03-31 | $134.7m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months, 2020-01-01 to 2020-03-31 | $77.6m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months, 2020-01-01 to 2020-03-31 | $57.1m | us-gaap:GrossProfit |
| Research and development | 3 months, 2020-01-01 to 2020-03-31 | $19.2m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months, 2020-01-01 to 2020-03-31 | $56.1m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months, 2020-01-01 to 2020-03-31 | −$18.2m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months, 2020-01-01 to 2020-03-31 | −$1.9m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2020-01-01 to 2020-03-31 | −$18.9m | us-gaap:NetIncomeLoss |
| Operating cash flow | 3 months, 2020-01-01 to 2020-03-31 | −$2.3m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months, 2020-01-01 to 2020-03-31 | $4.4m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | at 2020-03-31 | $112.8m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2020-03-31 | $367.5m | us-gaap:AssetsCurrent |
| Total assets | at 2020-03-31 | $783.7m | us-gaap:Assets |
| Current liabilities | at 2020-03-31 | $166.3m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2020-03-31 | $295.0m | us-gaap:Liabilities |
| Long-term debt | at 2020-03-31 | $44.6m | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | at 2020-03-31 | $2.5m | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | at 2020-03-31 | $488.7m | us-gaap:StockholdersEquity |

## Management's discussion and analysis

As filed, 35,751 characters.

The following discussion and analysis should be read together with the unaudited condensed consolidated financial statements and the notes thereto included in Item 1 (the “Financial Statements”) of this Quarterly Report on Form 10-Q (“Form 10-Q”). Also, we are subject to a number of risks and uncertainties that may affect our future performance that are discussed in greater detail in the sections entitled “Forward-Looking Statements” at the end of this Item 2 and that are discussed or referred to in Item 1A of Part II of this Form 10-Q.

### Business Overview

3D Systems Corporation (“3D Systems” or the “Company” or “we” or “us”) is a holding company incorporated in Delaware in 1993 that markets our products and services through subsidiaries in North America and South America (collectively referred to as “Americas”), Europe and the Middle East (collectively referred to as “EMEA”) and the Asia Pacific region (“APAC”). We provide comprehensive 3D printing and digital manufacturing solutions, including 3D printers for plastics and metals, materials, software, on demand manufacturing services and digital design tools. Our solutions support advanced applications in a wide range of industries and verticals, including healthcare, dental, aerospace, automotive and durable goods. Our precision healthcare capabilities include simulation; Virtual Surgical Planning (VSP®)(“VSP”); and printing of medical and dental devices, models, and surgical guides and instruments. We have over 30 years of experience and expertise which have proven vital to our development of an ecosystem and end-to-end digital workflow solutions which enable customers to optimize product designs, transform workflows, bring innovative products to market and drive new business models.

Customers can use our 3D solutions to design and manufacture complex and unique parts, eliminate expensive tooling, produce parts locally or in small batches and reduce lead times and time to market. A growing number of customers are shifting from prototyping applications to also using 3D printing for production. We believe this shift will be further driven by our continued advancement and innovation of 3D printing solutions that improve durability, reliability, repeatability and total cost of operations.

### COVID-19 Pandemic Response

Our top priority during the ongoing COVID-19 pandemic remains the health and safety of our employees and their families. As global governments institute restrictions on commercial operations, we are working to ensure our compliance while also maintaining business continuity for operations.

While no company is immune to global economic challenges, our business portfolio is well-balanced across end markets and geographies, and includes a high degree of businesses serving critical sectors such as the healthcare, aerospace and durable goods. Our balance sheet is well positioned and had $112.8 million of cash and cash equivalents at March 31, 2020, and a committed revolving credit facility maturing in 2024 with $42.2 million of credit available at March 31, 2020. We are in discussions with our lenders to ensure continued availability of funds in future quarters given the prospect of further economic downturn.

#### Our Employees

We are in the midst of what is a historic deployment of remote work and digital access to services. Our Crisis Response Steering Committee is highly engaged with local site leaders across our company in safeguarding the well-being of our employees and minimizing the spread of this infection. Employees whose tasks can be done offsite have been instructed to work from home. Approximately 80% of our total personnel continue to work from home. We only allow employees in our facilities who are essential to the facilities’ operations under best practices guidelines on maintaining physical distancing, utilizing enhanced cleaning protocols and usage of personal protective equipment.

#### Our Customers

We are committed to our customers to enable the support they need to continue providing vital services and tools. Our global businesses and manufacturing sites remain operational to meet customer needs during the pandemic in compliance with the orders and restrictions imposed by government authorities in each of our locations, and we are working with our customers to meet their specific shipment needs. While the pandemic has created minor delays on the inbound supply chain at our partners and our own facilities and both inbound and outbound logistical challenges, we have been able to identify alternative solutions such that none of the issues have had a material impact on our ability to fulfill demand.

#### Our Community

Our team has worked hard to connect people in need during this pandemic with those who can help using digital manufacturing solutions. Together with our committed partners and customers, we have worked to architect solutions specific to user needs through a combination of materials, hardware platforms, software and professional services. This helps to integrate additive manufacturing into traditional production environments and allows companies to reduce dependency on the supply chain, manufacture parts internally or make them on demand. Additionally, the COVID-19 pandemic has created the need for protective measures for both healthcare professionals and patients resulting from bottlenecks and shortages in the worldwide supply of personal protective equipment and other vital medical devices and equipment.

In response. we asked our network of partners, customers and others within the additive manufacturing community to circumvent the supply chain and help produce these parts as quickly as possible, to meet the urgent needs of the healthcare sector as they care for patients and contain the spread of the COVID-19 virus. We received offers from the community for everything from printer materials, usage of facilities for printing, engineers’ time and expertise and even offers to fund efforts. We believe that collaboration like this will be key to saving lives.

We have collaborated with our additive manufacturing community on several projects to combat the effect of the pandemic. We identified face shields as being something additive manufacturing could quickly support. We designed and developed a high efficiency face shield frame. Our printers can output 100 face shields every 24 hours. We offer this the data file free of charge to the additive manufacturing community in order to enable others who have an SLS printer to go from CAD file to production in minutes.

Lonati SpA, a manufacturing company based in Brescia, Italy, deployed our ProX SLS 6100 printer with DuraForm materials to 3D print more than 100 venturi ventilator valves for respiratory machines. These valves were designed, developed, produced and delivered in just three days, evidencing the key capabilities of our technology and the value proposition of fast response time. We now have ventilator projects going on all over the world, including in hospitals, and we are working with the National Health Service in the United Kingdom on venturi valves that can be deployed quickly and close to the point of care.

With the recent trend of moving from ventilators to CPAP masks for treatment of infected patient, we have been involved in the production of CPAP adapter components, turning what would have been a one to two month project into a solution on day one, with unit build time of just over one hour and a finished product the same day.

Finally, as widespread diagnostic testing of COVID-19 begins to ramp, there are known shortages of diagnostic tools such as nasal swabs. Our customers have been looking at repurposing dental and industrial Figure 4 printers to 3D print nasal swabs using dental and industrial grade resins as well as medical grade nylon 12. A single Figure 4 printer has demonstrated the ability to produce over 18,000 swabs per week. We have received interest from both hospitals and OEMs and are currently engaged in clinical validations with several teams.

These activities demonstrate our thought leadership in additive manufacturing, our commitment to partnering with our community in combating the pandemic and a balanced approach to how our industry can quickly address supply and demand needs amid COVID-19.

#### Looking Forward

Our operations in Americas, EMEA and APAC expose us to risks associated with public health crises and epidemics/pandemics, such as the COVID-19 pandemic. While the COVID-19 pandemic has impacted the Company’s reported results for the first quarter, we are unable to predict the longer term impact that the pandemic may have on our business, results of operations, financial position or cash flows. The extent to which our operations may be impacted by the dynamic nature of the COVID-19 pandemic will depend largely on future developments, which are highly uncertain and cannot be accurately predicted, including new information which may emerge concerning the severity of the outbreak and actions by government authorities to contain the outbreak or treat its impact. Furthermore, the impacts of a potential worsening of global economic conditions and the continued disruptions to, and volatility in the financial markets remain unknown. Additional information regarding COVID-19 risks appears in Part II, Item 1A, “Risk Factors” of this Form 10-Q.

### Summary of First Quarter 2020 Financial Results

Total consolidated revenue for the quarter ended March 31, 2020 decreased by 11.4%, or $17.3 million, to $134.7 million, compared to $152.0 million for the quarter ended March 31, 2019. These results reflect a 35.5% decrease in printers revenue and a 12.8% decrease from on demand manufacturing revenue as our customers purchases were impacted by the COVID-19 pandemic. Materials revenue decreased 0.1% to $41.4 million.

Healthcare revenue includes sales of products, materials and services for healthcare-related applications, including simulation, training, planning, anatomical models, surgical guides and instruments and medical and dental devices. For the quarter ended March 31, 2020, healthcare revenue decreased by 7.3%, to $46.3 million, and made up 34.4% of total revenue, compared to $50.0 million, or 32.9% of total revenue, for the quarter ended March 31, 2019.

For the quarter ended March 31, 2020, total software revenue from products and services decreased by 7.7% to $21.2 million, and made up 15.7% of total revenue, compared to $23.0 million, or 15.1% of total revenue, for the quarter ended March 31, 2019.

Gross profit for the quarter ended March 31, 2020 decreased by 13.0%, or $8.6 million, to $57.1 million, compared to $65.7 million for the quarter ended March 31, 2019. Gross profit margin for the quarters ended March 31, 2020 and March 31, 2019 was 42.4% and 43.2%, respectively.

Operating expenses for the quarter ended March 31, 2020 decreased by 13.4%, or $11.7 million, to $75.4 million, compared to $87.0 million for the quarter ended March 31, 2019. Selling, general and administrative expenses for the quarter ended March 31, 2020 decreased by 13.8%, or $9.0 million, to $56.1 million, compared to $65.1 million for the quarter ended March 31, 2019. Research and development expenses for the quarter ended March 31, 2020 decreased by 12.1%, or $2.7 million, to $19.2 million, compared to $21.9 million for the quarter ended March 31, 2019. Lower operating expenses reflect savings from 2019 cost optimization activities as well as short term cost savings from reduced hiring, travel, and outside service expenses.

Our operating loss for the quarter ended March 31, 2020 was $18.2 million, compared to an operating loss of $21.3 million for the quarter ended March 31, 2019.

For the quarters ended March 31, 2020 and March 31, 2019, we used $2.3 million and $15.2 million of cash from operations, respectively, as further discussed below. In total, our unrestricted cash balance at March 31, 2020 and December 31, 2019, was $112.8 million and $133.7 million, respectively. The lower cash balance was primarily the result of the $10.0 million payment to acquire the remaining capital and voting rights of the noncontrolling interest in Brazil, $4.4 million in capital expenditures, and a $3.2 million negative effect of exchange rates.

### Results of Operations

#### Comparison of revenue

Due to the relatively high price of certain 3D printers and a corresponding lengthy selling cycle as well as relatively low unit volume of the higher priced printers in any particular period, a shift in the timing and concentration of orders and shipments from one period to another can affect reported revenue in any given period.

In addition to changes in sales volumes, there are two other primary drivers of changes in revenue from one period to another: (1) the combined effect of changes in product mix and average selling prices and (2) the impact of fluctuations in foreign currencies. As used in this Management’s Discussion and Analysis, the price and mix effects relate to changes in revenue that are not able to be specifically related to changes in unit volume.

#### Comparison of revenue by geographic region

The following table sets forth changes in revenue by geographic region for the quarters ended March 31, 2020 and 2019.

### Table 1

*(Dollars in thousands)*

|  | Americas |  | EMEA |  | Asia Pacific |  | Total |  |
| --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue — first quarter 2019 | $73,703 | 48.5% | $59,644 | 39.2% | $18,633 | 12.3% | $151,980 | 100.0% |
| Change in revenue: |  |  |  |  |  |  |  |  |
| Volume | (8,749) | (11.9)% | 927 | 1.6% | (5,367) | (28.8)% | (13,189) | (8.7)% |
| Price/Mix | (981) | (1.3)% | (3,500) | (5.9)% | 1,484 | 8.0% | (2,997) | (2.0)% |
| Foreign currency translation | (171) | (0.2)% | (604) | (1.0)% | (314) | (1.7)% | (1,089) | (0.7)% |
| Net change | (9,901) | (13.4)% | (3,177) | (5.3)% | (4,197) | (22.5)% | (17,275) | (11.4)% |
| Revenue — first quarter 2020 | $63,802 | 47.4% | $56,467 | 41.9% | $14,436 | 10.7% | $134,705 | 100.0% |

Consolidated revenue decreased by 11.4%, predominantly driven by lower sales volume in the Americas and Asia Pacific regions driven by plastics printers, on demand manufacturing, healthcare, and exiting the entertainment business in the prior year and unfavorable price/mix in the EMEA region driven by metals/material and healthcare; partially offset by favorable sales volume for metals printers in the Americas region.

For the quarters ended March 31, 2020 and 2019, revenue from operations outside the U.S. was 54.0% and 53.0% of total revenue, respectively.

#### Comparison of revenue by class

We earn revenue from the sale of products, materials and services. The products category includes 3D printers, healthcare simulators and digitizers, software licenses, 3D scanners and haptic devices. The materials category includes a wide range of materials to be used with our 3D printers, the majority of which are proprietary, as well as conventional dental materials. The services category includes maintenance contracts and services on 3D printers and simulators, software maintenance, on demand solutions and healthcare services.

The following table sets forth the change in revenue by class for the quarters ended March 31, 2020 and 2019.

### Table 2

*(Dollars in thousands)*

|  | Products |  | Materials |  | Services |  | Total |  |
| --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue — first quarter 2019 | $50,917 | 33.5% | $41,430 | 27.3% | $59,633 | 39.2% | $151,980 | 100.0% |
| Change in revenue: |  |  |  |  |  |  |  |  |
| Volume | (12,045) | (23.7)% | 2,021 | 4.9% | (3,165) | (5.3)% | (13,189) | (8.7)% |
| Price/Mix | (1,307) | (2.6)% | (1,690) | (4.1)% | — | —% | (2,997) | (2.0)% |
| Foreign currency translation | (133) | (0.3)% | (384) | (0.9)% | (572) | (1.0)% | (1,089) | (0.7)% |
| Net change | (13,485) | (26.5)% | (53) | (0.1)% | (3,737) | (6.3)% | (17,275) | (11.4)% |
| Revenue — first quarter 2020 | $37,432 | 27.8% | $41,377 | 30.7% | $55,896 | 41.5% | $134,705 | 100.0% |

Consolidated revenue decreased 11.4%, predominantly due to lower products volume which was driven by plastics and software. For the quarters ended March 31, 2020 and 2019, revenue from printers contributed $19.3 million and $29.9 million, respectively. Software revenue included in the products category, including scanners and haptic devices, contributed $10.8 million and $12.2 million for the quarters ended March 31, 2020 and 2019, respectively.

For the quarters ended March 31, 2020 and 2019, revenue from on demand manufacturing services contributed $19.7 million and $22.6 million, respectively. For the quarters ended March 31, 2020 and 2019, software services revenue contributed $10.4 million and $10.8 million, respectively.

#### Gross profit and gross profit margins

The following table sets forth gross profit and gross profit margins for the quarters ended March 31, 2020 and 2019.

### Table 3

*(Dollars in thousands)*

|  | Quarter Ended March 31, 2020 Gross Profit | Gross Profit Margin | 2019 Gross Profit | Gross Profit Margin | Change in Gross Profit $% |  | Change in Gross Profit Margin Percentage Points% |  |
| --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Products | $1,422 | 3.8% | $7,750 | 15.2% | $(6,328) | (81.7)% | (11.4) | (75.0)% |
| Materials | 28,491 | 68.9% | 28,837 | 69.6% | (346) | (1.2)% | (0.7) | (1.0)% |
| Services | 27,219 | 48.7% | 29,118 | 48.8% | (1,899) | (6.5)% | (0.1) | (0.2)% |
| Total | $57,132 | 42.4% | $65,705 | 43.2% | $(8,573) | (13.0)% | (0.8) | (1.9)% |

The decrease in total consolidated gross profit is due to the decrease in product sales, primarily lower sales of printers.

Products gross profit margin decreased primarily due to under absorption of supply chain overhead resulting from lower production, in addition to the impact of the mix of sales. Total gross profit margin reflects favorable mix.

#### Operating expenses

The following table sets forth the components of operating expenses for the quarters ended March 31, 2020 and 2019.

### Table 4

*(Dollars in thousands)*

|  | Quarter Ended March 31, 2020 Amount | % Revenue | 2019 Amount | % Revenue | Change $% |  |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Selling, general and administrative expenses | $56,106 | 41.7% | $65,107 | 42.8% | $(9,001) | (13.8)% |
| Research and development expenses | 19,244 | 14.3% | 21,903 | 14.4% | (2,659) | (12.1)% |
| Total operating expenses | $75,350 | 55.9% | $87,010 | 57.2% | $(11,660) | (13.4)% |

Selling, general and administrative expenses decreased due to lower employee costs from 2019 cost structure activities as well as short term cost savings from reduced hiring, travel, and outside service expenses.

Research and development expenses decreased due to lower employee costs from 2019 cost structure activities as well as lower program spend.

#### Loss from operations

The following table sets forth (loss) income from operations by geographic region for the quarters ended March 31, 2020 and 2019.

### Table 5

*(Dollars in thousands)*

| (Loss) income from operations: | Quarter Ended March 31, 2020 | 2019 |
| --- | ---: | ---: |
| Americas | $(22,087) | $(26,832) |
| EMEA | 2,228 | 2,917 |
| Asia Pacific | 1,641 | 2,610 |
| Total | $(18,218) | $(21,305) |

See “*Comparison of revenue by geographic region,” “Gross profit and gross profit margins”* and “*Operating expenses”* above.

#### Interest and other (expense) income, net

The following table sets forth the components of interest and other (expense) income, net, for the quarters ended March 31, 2020 and 2019.

### Table 6

*(Dollars in thousands)*

| Interest and other (expense) income, net | Quarter Ended March 31, 2020 | 2019 |
| --- | ---: | ---: |
| Foreign exchange (loss) gain | $(112) | $(1,039) |
| Interest expense, net | (1,038) | (576) |
| Other (expense) income, net | (1,414) | 414 |
| Total interest and other (expense) income, net | $(2,564) | $(1,201) |

The increase in total interest and other expense, net, for the quarter ended March 31, 2020 as compared to the quarter ended March 31, 2019 was primarily driven by losses recorded on investments.

#### Net loss attributable to 3D Systems

The following table sets forth the primary components of net loss attributable to 3D Systems for the quarters ended March 31, 2020 and 2019.

### Table 7

*(Dollars in thousands)*

|  | Quarter Ended March 31, 2020 | 2019 | Change |
| --- | ---: | ---: | ---: |
| Loss from operations | $(18,218) | $(21,305) | $3,087 |
| Other non-operating items: |  |  |  |
| Interest and other (expense) income, net | (2,564) | (1,201) | (1,363) |
| Benefit (provision) for income taxes | 1,858 | (1,844) | 3,702 |
| Net loss | (18,924) | (24,350) | 5,426 |
| Less: net income attributable to noncontrolling interests | — | 44 | (44) |
| Net loss attributable to 3D Systems Corporation | $(18,924) | $(24,394) | $5,470 |
| Weighted average shares, basic and diluted | 114,590 | 113,267 |  |
| Net loss per share - basic and diluted | $(0.17) | $(0.22) |  |

The decrease in net loss for the quarter ended March 31, 2020, as compared to the quarter ended March 31, 2019, was primarily driven by a decrease in loss from operations and the tax benefit associated with certain net operating loss tax carrybacks, partially offset by losses recorded on investments. See “*Gross profit and gross profit margins”* and “*Operating expenses”* above, and Note 12.

### Liquidity and Capital Resources

### Table 8

*(Dollars in thousands)*

|  | March 31, 2020 | December 31, 2019 | Change $% |  |
| --- | ---: | ---: | ---: | ---: |
| Cash and cash equivalents | $112,776 | $133,665 | $(20,889) | (15.6)% |
| Accounts receivable, net | 108,769 | 109,408 | (639) | (0.6)% |
| Inventories | 113,240 | 111,106 | 2,134 | 1.9% |
|  | 334,785 | 354,179 | (19,394) |  |
| Less: |  |  |  |  |
| Current portion of long term debt | 2,506 | 2,506 | — | —% |
| Current right of use liabilities | 9,416 | 9,569 | (153) | (1.6)% |
| Accounts payable | 55,862 | 49,851 | 6,011 | 12.1% |
| Accrued and other liabilities | 50,803 | 63,095 | (12,292) | (19.5)% |
|  | 118,587 | 125,021 | (6,434) |  |
| Operating working capital | $216,198 | $229,158 | $(12,960) | (5.7)% |

We assess our liquidity in terms of our ability to generate cash to fund our operating, investing and financing activities. In doing so, we review and analyze our current cash on hand, the number of days our sales are outstanding, inventory turns, capital expenditure commitments and accounts payable turns. Our cash requirements primarily consist of funding working capital and capital expenditures.

Cash flow from operations, cash and cash equivalents, and other sources of liquidity such as bank credit facilities and issuing equity or debt securities, are expected to be available and sufficient to meet foreseeable cash requirements. We hold a 5-year $100,000 senior secured term loan facility (the “Term Facility”) and a 5-year $100,000 senior secured revolving credit facility (the “Revolving Facility” and, together with the Term Facility, the “Senior Credit Facility”) that are intended to support working capital and general corporate purposes. The Senior Credit Facility is scheduled to mature on February 26, 2024, at which time all amounts outstanding thereunder will be due and payable. As of March 31, 2020, we have availability under the Revolving Facility of $42.2 million. For additional information on the Senior Credit Facility, see Note 7 to the condensed consolidated financial statements in this Form 10-Q.

Cash held outside the U.S. at March 31, 2020 was $72.9 million, or 64.7% of total cash and equivalents, compared to $75.7 million, or 56.5% of total cash and equivalents at December 31, 2019. As our previously unremitted earnings have been subjected to U.S. federal income tax, we expect any repatriation of these earnings to the U.S. would not incur significant additional taxes related to such amounts. However, our estimates are provisional and subject to further analysis. Cash equivalents are comprised of funds held in money market instruments and are reported at their current carrying value, which approximates fair value due to the short term nature of these instruments. We strive to minimize our credit risk by investing primarily in investment grade, liquid instruments and limit exposure to any one issuer depending upon credit quality. See “Cash flow” discussion below.

Days’ sales outstanding (DSO) was 73 at March 31, 2020, compared to 67 days for the year at December 31, 2019. Accounts receivable more than 90 days past due decreased to 10.3% of gross receivables at March 31, 2020, from 12.1% at December 31, 2019. We review specific receivables periodically to determine the appropriate reserve for accounts receivable.

The majority of our inventory consists of finished goods, including products, materials and service parts. Inventory also consists of raw materials for certain printers and service products. Inventory balances may fluctuate during cycles of new product launch, commercialization and timing of ramp up of production and sales of products.

The changes that make up the other components of working capital not discussed above resulted from the ordinary course of business. Differences between the amounts of working capital item changes in the cash flow statement and the balance sheet changes for the corresponding items are primarily the result of foreign currency translation adjustments.

### Cash flow

#### Cash flow from operations

Cash used in operating activities for the quarters ended March 31, 2020 and March 31, 2019 was $2.3 million and $15.2 million, respectively. Excluding non-cash charges, the net loss provided cash of $1.0 million for the quarter ended March 31, 2020 and used cash of $4.6 million for the quarter ended March 31, 2019. Non-cash charges generally consist of depreciation, amortization, and stock-based compensation.

Working capital used cash of $3.3 million and $10.6 million for the quarters ended March 31, 2020 and March 31, 2019, respectively. In the quarter ended March 31, 2020, drivers of working capital related to cash outflows were an increase in prepaid expenses and inventory and a decrease in other accrued liabilities; partially offset by a increase in deferred revenue and accounts payable. In the quarter ended March 31, 2019, cash outflows were mainly due to lower accounts payable, lower accrued liabilities and investments in inventory to support of new product commercialization, partially offset by an increase deferred revenues related to software and system maintenance contracts.

#### Cash flow from investing activities

For the quarters ended March 31, 2020 and 2019, the primary outflows of cash relate to the purchases of noncontrolling interest and capital expenditures.

#### Cash flow from financing activities

Cash provided by financing activities was $1.2 million and $73.7 million for the quarters ended March 31, 2020 and March 31, 2019, respectively. The primary inflow of cash for the quarter ended March 31, 2020 relates to the proceeds from the inventory financing agreements, partially offset by settlements of stock-based compensation and repayment of the Term Facility. The primary inflow of cash for the quarter ended March 31, 2019 relates to borrowing on the Term Facility, partially offset by repayments of the Prior Credit Facility and Term Facility.

### Recent Accounting Pronouncements

Refer to Note 1 - Basis of Presentation of the Notes to Financial Statements (Part I, Item 1 of this Form 10-Q) for further discussion.

### Critical Accounting Policies and Significant Estimates

Our condensed consolidated financial statements are prepared in accordance with GAAP. The preparation of these condensed consolidated financial statements requires us to make certain estimates and assumptions that affect the reported amounts of assets, liabilities, revenues, costs and expenses, and related disclosures. On an ongoing basis, we evaluate our estimates and assumptions. Our actual results may differ from these estimates under different assumptions or conditions.

As of the date of this report, there have been no changes to our critical accounting policies and estimates described in the Annual Report on Form 10-K for the year ended December 31, 2019 (“2019 Form 10-K”), filed with the Securities and Exchange Commission (“SEC”) on February 26, 2020 that have had a material impact on our condensed consolidated financial statements and related notes, other than the following:

Our EMEA, APAC and Americas reporting units carry approximately $182.9 million, $35.3 million and $0 of goodwill, respectively, as of March 31, 2020. Goodwill in the Americas region was written off in 2015. The net carrying values of our long-lived assets in the EMEA, APAC, and Americas regions are approximately $63.6 million, $6.8 million, and $62.8 million, respectively. In our 2019 impairment testing, we determined the EMEA and APAC reporting units had fair values in excess of their carrying values. Our 2019 impairment testing also indicated no impairment of long-lived assets in the Americas region as the undiscounted cash flows were in excess of the carrying value of long-lived assets. This headroom and recoverability were driven by our forecasts of future operating performance as well as external market indicators.

Our operating performance through March 31, 2020 has been negatively impacted by macroeconomic factors, the decrease and mix of sales, and the effect of the COVID-19 pandemic. The Company is taking actions to counter these factors, including reducing our cost structure by focusing on cost of sales and operating expenses to drive future profitability. Refer to discussion of the COVID-19 Pandemic in this Management’s Discussion and Analysis. As a results of these matters, the Company experienced a triggering event in the current quarter and performed a quantitative analysis for potential impairment of its goodwill or long-lived asset balances. Based on currently available information and analysis as of March 31, 2020, the Company continues to believe the fair value of the reporting units exceeds their carrying values and the carrying value of our long-lived assets is recoverable. In the event that these matters are not satisfactorily resolved, the Company could experience another triggering event or impairment of its goodwill or long-lived asset balances in future periods.

### Forward-Looking Statements

Certain statements made in this Form 10-Q that are not statements of historical or current facts are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, performance or achievements to be materially different from historical results or from any future results expressed or implied by such forward-looking statements. In many cases, you can identify forward-looking statements by terms such as “believes,” “belief,” “expects,” “estimates,” “intends,” “anticipates,” or “plans” or the negative of these terms or other comparable terminology.

Forward-looking statements are based upon management’s beliefs, assumptions and current expectations concerning future events and trends, using information currently available, and are necessarily subject to uncertainties, many of which are outside our control. Although we believe that the expectations reflected in the forward-looking statements are reasonable, forward-looking statements are not, and should not be relied upon as a guarantee of future performance or results, nor will they necessarily prove to be accurate indications of the times at or by which any such performance or results will be achieved. A number of important factors could cause actual results to differ materially from those indicated by the forward-looking statements. These factors include without limitation:

- impact of production, supply, contractual and other disruptions, including facility closures and furloughs, due to the spread of the COVID-19 pandemic;
- our ability to deliver products that meet changing technology and customer needs;
- our ability to identify strategic acquisitions, to integrate such acquisitions into our business without disruption and to realize the anticipated benefits of such acquisitions;
- impact of future write-off or write-downs of intangible assets;
- our ability to acquire and enforce intellectual property rights and defend such rights against third party claims;
- our ability to protect our intellectual property rights and confidential information, including our digital content, from third-party infringers or unauthorized copying, use or disclosure;
- failure of our information technology infrastructure or inability to protect against cyber-attack;
- our ability to generate net cash flow from operations;
- our ability to obtain additional financing on acceptable terms;
- our ability to comply with the covenants in our borrowing agreements;
- impact of natural disasters, public health issues (including the COVID-19 pandemic), and other catastrophic events;
- impact of global economic, political and social conditions and financial markets on our business;
- fluctuations in our gross profit margins, operating income or loss and/or net income or loss;
- our ability to efficiently conduct business outside the U.S.;
- our dependence on our supply chain for components and sub-assemblies used in our 3D printers and other products and for raw materials used in our print materials;
- our ability to manage the costs and effects of litigation, investigations or similar matters involving us or our subsidiaries;
- product quality problems that result in decreased sales and operating margin, product returns, product liability, warranty or other claims;
- our ability to retain our key employees and to attract and retain new qualified employees, while controlling our labor costs;
- our exposure to product liability claims and other claims and legal proceedings;
- disruption in our management information systems for inventory management, distribution, and other key functions;
- compliance with U.S. and other anti-corruption laws, data privacy laws, trade controls, economic sanctions, and similar laws and regulations;
- our ability to comply with the terms of the Administrative Agreement with the U.S. Air Force and to maintain our status as a responsible contractor under federal rules and regulations;
- changes in, or interpretation of, tax rules and regulations; and
- compliance with, and related expenses and challenges concerning, conflict-free minerals regulations; and
- the other factors discussed in the reports we file with or furnishes to the SEC from time to time, including the risks and important factors set forth in additional detail in Item 1A. “Risk Factors” in the 2019 Form 10-K and in Part II, Item 1A of the Form 10-Q.

Readers are cautioned not to place undue reliance on these forward-looking statements. The forward-looking statements included herein are made only as of the date of this Form 10-Q and we undertake no obligation to publicly update or review any forward-looking statement made by us or on our behalf, whether as a result of new information, future developments, subsequent events or circumstances or otherwise. All subsequent written or oral forward-looking statements attributable to us or individuals acting on our behalf are expressly qualified in their entirety by the cautionary statements referenced above.

## Market risk

As filed, 331 characters.

For a discussion of market risks at December 31, 2019, refer to Item 7A. “Quantitative and Qualitative Disclosures about Market Risk” in the 2019 Form10-K. During the first three months of 2020, there were no material changes or developments that would materially alter the market risk assessment performed as of December 31, 2019.

## Controls and procedures

As filed, 1,457 characters.

#### Evaluation of disclosure controls and procedures

As of March 31, 2020, we carried out an evaluation, under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) pursuant to Rules 13a-15 and 15d-15 under the Exchange Act. These controls and procedures were designed to provide reasonable assurance that the information required to be disclosed in the reports that we file or submit under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, in a manner to allow timely decisions regarding required disclosures. Based on this evaluation, management has concluded that our disclosure controls and procedures were effective as of March 31, 2020.

### Changes in Internal Controls over Financial Reporting

There were no material changes in our internal controls over financial reporting during the period covered by this Form 10-Q that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

## Risk factors

As filed, 14,194 characters.

There are no material changes to the risk factors previously disclosed in our 2019 Form 10-K in response to Item 1A to Part I of Form 10-K other than below. However, the impact of the COVID-19 pandemic may exacerbate the risks discussed below and in Item 1A, “Risk Factors” in our 2019 Form 10-K, any of which could have a material effect on us. This situation is changing rapidly and additional impacts may arise that we are not aware of currently. See also Part I Item 2, Management’s Discussion and Analysis of Financial Condition and Results of Operations for additional information regarding our response to the COVID-19 pandemic and Part I Item 3, Quantitative and Qualitative Disclosures About Market Risk.

**The COVID-19 pandemic could materially adversely affect our financial condition and results of operations.**

The novel strain of the coronavirus identified in China in late 2019 (COVID-19) has globally spread throughout other areas such as Asia, Europe, the Middle East, and North America and has resulted in authorities imposing, and businesses and individuals implementing, numerous unprecedented measures to try to contain the virus, such as travel bans and restrictions, quarantines, shelter-in-place/stay-at-home and social distancing orders, and shutdowns. These measures have impacted and may further impact our workforce and operations, the operations of our customers, and those of our respective vendors, suppliers, and partners. Each of the countries in which we operate has been affected by the outbreak and taken measures to try to contain it. The ultimate impact and efficacy of government measures and potential future measures is currently unknown.

There is considerable uncertainty regarding the business impacts from such measures and potential future measures. While we have been able to continue our operations through a combination of work-from-home and social distancing policies implemented to protect employees, these measures have resulted in reduced workforce availability at some of our sites. Restrictions on our access to customer facilities may impact our ability to meet customer demand and could have a material adverse effect on our financial condition and results of operations, particularly if prolonged. Our customers have experienced, and may continue to experience, disruptions in their operations, which can result in delayed, reduced, or canceled orders, or collection risks, and which may adversely affect our results of operations.

The pandemic has significantly increased economic and demand uncertainty. It is likely that the current outbreak and continued spread of COVID-19 will cause an economic slowdown, and it is possible that it could cause a global recession. There is a significant degree of uncertainty and lack of visibility as to the extent and duration of any such slowdown or recession. Risks related to a slowdown or recession are described in our risk factor titled “Global economic, political and social conditions and financial markets may harm our ability to do business, adversely affect our sales, costs, results of operations and cash flow,” below, and include the risk that demand for our products and services will be significantly harmed. Given the significant economic uncertainty and volatility created by the pandemic, it is difficult to predict the nature and extent of impacts on demand for our products and services. These expectations are subject to change without warning and investors are cautioned not to place undue reliance on them.

The pandemic has led to increased disruption and volatility in capital markets and credit markets. We implemented salary decreases for executives, 2-week furloughs for non-essential employees, and suspension of all non-essential capital expenditures measures to strengthen our liquidity position given the uncertainty regarding the length and severity of the pandemic and ongoing economic uncertainty. Unanticipated consequences of the pandemic and resulting economic uncertainty could result in a breach of the debt financial covenant, thus adversely affecting our liquidity and capital resources in the future, as well as incurring additional costs if an amendment to the credit agreement is required.

The spread of COVID-19 has caused us to modify our business practices (including employee travel, employee work locations, cancellation of physical participation in meetings, events and conferences, and social distancing measures), and we may take further actions as may be required by government authorities or that we determine are in the best interests of our employees, customers, partners, vendors, and suppliers. Work-from-home and other measures introduce additional operational risks, including cybersecurity risks, and have affected the way we conduct our product development and testing, customer support, and other activities, which could have an adverse effect on our operations. There is no certainty that such measures will be sufficient to mitigate the risks posed by the virus, and illness and workforce disruptions could lead to unavailability of key personnel and harm our ability to perform critical functions.

**We depend on outsourcing partners for assembly of our 3D printers and our supply chain for spare parts and for raw materials used in our materials. The ongoing COVID-19 pandemic has caused supply and logistical disruptions for both our outsourcing partners and supply chain partners. If these relationships were to terminate or these disruptions worsen, our business could be disrupted while we locate alternative suppliers and our expenses may increase.**

We have outsourced selected design and manufacturing companies to assemble our printers. In carrying out these outsourcing activities, we face a number of risks, including, among others, the following:

- The risk that the parties that we retain to perform assembly activities may not perform in a satisfactory manner;
- The risk of disruption in the supply of printers or other products to our customers if such third parties either fail to perform in a satisfactory manner or are unable to supply us with the quantity of printers or other products that are needed to meet then current customer demand;
- The risk of work delays or supply chain disruptions stemming from governmental efforts to contain the COVID-19; and
- The risk of insolvency of suppliers, as well as the risks that we face, as discussed below, in dealing with a limited number of suppliers.

We purchase components and sub-assemblies for our printers from third-party suppliers that we provide to our customers as spare parts. Additionally, we purchase raw materials that are used in our materials, as well as certain of those materials, from third-party suppliers.

While there are several potential suppliers of parts for our products, we currently choose to use only one or a limited number of suppliers for several of these items, including our lasers, materials and certain jetting components. Our reliance on a single or limited number of suppliers involves many risks, including, among others, the following:

- Potential shortages of some key components;
- Disruptions in the operations of these suppliers;
- Product performance shortfalls; and
- Reduced control over delivery schedules, assembly capabilities, quality and costs.

The recent situation brought on by COVID-19 pandemic has created minor delays on the inbound supply chain at our partners and our own facilities. Additional delays on both inbound and outbound logistics have also created challenges. We have been able to identify alternative solutions such that none of the issues have had a material impact on our ability to fulfill demand.

While we believe that, if necessary, we can obtain all the components necessary for our spare parts and materials from other manufacturers, we require any new supplier to become “qualified” pursuant to our internal procedures, which could involve evaluation processes of varying durations. Our spare parts and raw materials used in our materials production are subject to various lead times. In addition, at any time, certain suppliers may decide to discontinue production of a part or raw material that we use. Any unanticipated change in the sources of our supplies, or unanticipated supply limitations, could increase production or related costs and consequently reduce margins.

If our forecasts exceed actual orders, we may hold large inventories of slow-moving or unusable parts, which could have an adverse effect on our cash flow, profitability and results of operations. Inversely, we may lose orders if our forecast is low and we are unable to meet demand. There is considerable uncertainty on the business impact from current measures and potential future measures to contain the spread of the COVID-19 pandemic on our vendors, suppliers, and partners, especially if such measures are in effect for an extended period of time. If disruptions to global businesses from the pandemic continue or worsen, our business could face greater supply chain delays and difficulty shipping or receiving products and materials, which could have a material adverse effect on our financial condition and results of operations.

**Global economic, political and social conditions and financial markets may harm our ability to do business, adversely affect our sales, costs, results of operations and cash flow.**

We are subject to global economic, political and social conditions that may cause customers to delay or reduce technology purchases due to economic downturns, difficulties in the financial services sector and credit markets, geopolitical uncertainties, tariffs and other macroeconomic factors affecting spending behavior. Adverse changes in global or regional economic conditions, including recession or slowing growth, lower capital expenditures by businesses, increases in unemployment, and lower consumer confidence and spending, periodically occur.

The COVID-19 pandemic has significantly increased economic and demand uncertainty. It is likely that the current outbreak and continued spread of COVID-19 will cause an economic slowdown, and it is possible that it could cause a global recession. Adverse changes in economic conditions, including as a result of the pandemic, can significantly harm demand for our products and services and make it more challenging to forecast our operating results and make business decisions, including regarding prioritization of investments in our business. An economic downturn or increased uncertainty may also lead to increased credit and collectability risks, reduced liquidity, and asset impairments.

We also face risks that may arise from financial difficulties experienced by our suppliers, resellers or customers, including, among others, the following:

- Customers or partners to whom we sell our products and services may face financial difficulties or may become insolvent, which could lead to our inability to obtain payment of accounts receivable that those customers may owe;
- Customers and potential customers may experience deterioration of their businesses, which may result in the delay or cancellation of plans to purchase our products;
- Key suppliers of raw materials, finished products or components used in the products that we sell may face financial difficulties or may become insolvent, which could lead to disruption in the supply of printers, materials or spare parts to our customers; and
- The inability of customers, including resellers, suppliers and contract manufacturers, to obtain credit financing to finance purchases of our products and raw materials used to build those products.

**Changes in business conditions may cause goodwill and other intangible assets to become impaired.**

Goodwill and other intangible assets are subject to an impairment test on an annual basis and when circumstances indicate that an impairment is more likely than not. Such circumstances include a significant adverse change in the business climate or a decision to dispose of a business or product line. We face some uncertainty in our business environment due to a variety of challenges, including changes in customer demand. We may experience unforeseen circumstances that adversely affect the value of our goodwill or intangible assets and trigger an evaluation of the amount of the recorded goodwill and intangible assets. Future write-offs of goodwill or other intangible assets as a result of an impairment in the business could materially adversely affect our results of operations and financial condition.

Our EMEA, APAC and Americas reporting units carry approximately $182.9 million, $35.3 million and $0 of goodwill, respectively, as of March 31, 2020. Goodwill in the Americas region was written off in 2015. The net carrying values of our long-lived assets in the EMEA, APAC, and Americas regions are approximately $63.6 million, $6.8 million, and $62.8 million, respectively. In our 2019 impairment testing, we determined that no impairment of goodwill or long-lived assets was required. These conclusions were driven by our forecasts of future operating performance as well as external market indicators.

Our operating performance through March 31, 2020 has been negatively impacted by macroeconomic factors, the decrease and mix of sales and the effect of the COVID-19 pandemic. As a result of these matters, the Company experienced a triggering event in the current quarter and performed a quantitative analysis for potential impairment of its goodwill or long-lived asset balances. Based on currently available information and analysis as of March 31, 2020, the Company continues to believe the fair value of the reporting units exceeds their carrying values and the carrying value of our long-lived assets is recoverable. The Company is taking actions to counter these factors, including reducing our cost structure by focusing on cost of sales and operating expenses to drive future profitability. In the event that these matters are not satisfactorily resolved, we could experience another triggering event or impairment of goodwill or long-lived asset balances in future periods.

Filed May 6, 2020.
Source: SEC EDGAR, the filing index for accession 0000910638-20-000018. Last ingested by Listed: Nov 15, 2026, 00:01 ET. No prices; not investment advice.
